The ELP1 gene helps nerve cells grow, stay healthy, and carry signals that control sensation and automatic body functions such as tears, swallowing, heart rate, and blood pressure. This gene plays an important role in how cells use genetic instructions so proteins are made and handled properly. When both copies of the ELP1 gene have pathogenic variants that greatly reduce its function, it causes familial dysautonomia, a condition that affects the nerves and can lead to feeding problems, reduced pain or temperature sensing, and blood pressure swings. ELP1 is mainly known in medicine rather than popular culture.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or direct processes throughout the body. Some carry the code for proteins, the parts of cells that do much of the work. Others mainly control when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, and medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
ELP1Gene function
What if the gene works
The ELP1 gene helps nerve cells grow, connect, and stay healthy. It also supports normal protein building inside cells, which is especially important in the brain and nerves.
Risk
What if the gene does not work
When both copies of the ELP1 gene do not work properly, this causes familial dysautonomia, affecting feeling and automatic body functions like blood pressure, tears, and swallowing. Milder and more severe variants can influence symptom timing and severity.
Treatment
What does that mean for your treatment
No ELP1-specific treatment or drug selection approach is currently established in clinical guidelines. Care is based on symptom management rather than changing medicines because of an ELP1 variant. The ELP1 gene is being studied as a treatment target in familial dysautonomia, including medicines that aim to improve normal ELP1 splicing and raise ELP1 protein levels.
Conditions associated with ELP1
Gene function
What if the gene works
In everyday cell life, the ELP1 gene helps cells read genetic instructions and turn them into proteins. It does this as part of the elongator complex, a group of proteins that supports smooth gene reading and protein building. When this system works properly, routine cell activity stays organized.
The ELP1 gene helps add small chemical marks to transfer RNA, the helper molecules that let cells read the genetic code. These marks make it easier for cells to build proteins smoothly and accurately.
ELP1 provides a main support piece for the elongator complex, a group of proteins that works together inside cells. This lets the complex stay assembled and carry out its routine tasks.
As part of the elongator complex, the ELP1 gene supports the step where cells copy selected genetic instructions into RNA. This helps keep protein production coordinated with everyday cell needs.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ELP1 gene often reduce the amount of working ELP1 protein, most commonly by disrupting RNA splicing (the step where cells edit a gene message before making protein). This can destabilize the Elongator complex and impair transfer RNA processing, which affects how cells build proteins. In familial dysautonomia, milder variants may leave some protein activity, while more severe variants can sharply reduce or nearly eliminate it. This range helps explain how ELP1 gene variants affect protein function and symptom severity.
How variants are linked to conditions
Pathogenic variants in the ELP1 gene cause familial dysautonomia, an inherited condition that affects sensation and automatic body functions such as blood pressure, tears, swallowing, and digestion. This is the main well-established ELP1 gene variant condition association in human genetics. A diagnosis is typically confirmed when a person has disease-causing variants in both copies of the gene, while carriers with one variant usually do not develop the condition.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are common across the general population. Most variants do not directly affect health and instead represent natural human diversity. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ELP1, risk is mainly shaped by family history and whether both parents carry a disease-causing change in this gene. Many living with ELP1-related conditions inherit changes in both copies, so lifestyle does not meaningfully change the chance of having the condition. Early diagnosis and regular care can still help lower the risk of complications.
Inheritance of ELP1 variants
For the best-known condition linked to the ELP1 gene, ELP1 gene inheritance follows an autosomal recessive pattern. This means a child usually inherits one variant in the ELP1 gene from each parent, and both parents are typically healthy carriers. When both parents carry an ELP1 variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is also a carrier, and a 25% chance of a child who inherits neither variant.
What does my ELP1 result mean for my family?
For ELP1, family impact is usually discussed in relation to familial dysautonomia, a condition that is inherited in a recessive way. This often means parents, brothers, sisters, and future children may want to know whether they also carry the changed gene, especially in families with Ashkenazi Jewish ancestry, where carrier status is more common. Brothers and sisters may have a chance of being affected or being carriers, while other relatives may also carry the variant without having symptoms.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the ELP1 gene, a lab can analyze DNA from blood, saliva, or a cheek swab. This is how genetic testing for ELP1 variants works: the lab reads the gene’s DNA code and classifies changes as harmful, likely harmful, harmless, or uncertain.
When should I consider getting a genetic test?
Genetic testing for ELP1 may be worth considering if familial dysautonomia runs in your family, if you or your child have signs of this rare inherited nerve condition, or if you have Ashkenazi Jewish ancestry and are planning a pregnancy.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same drug at the same dose, yet one may get the intended benefit while the other may notice less effect or more side effects. This happens in part because inherited differences can change how the body breaks down, transports, or responds to a medication, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medication. It looks at gene-drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes influence both how strong a drug’s effects are and how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the ELP1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects may happen. Questions about treatment changes, side effects, or other medication concerns are best discussed with your doctor or pharmacist.
History
ELP1 entered medical genetics through work on familial dysautonomia, a condition recognized for many decades in children from Ashkenazi Jewish families. In the 1990s, researchers mapped the cause to chromosome 9, and in 2001 the responsible gene was identified and widely reported as the IKBKAP gene. Building on this early work, scientists uncovered more about the gene and later updated its name to the ELP1 gene to better reflect its place in a larger cellular complex. That discovery made genetic testing much more precise for affected families and for carrier screening. The gene’s history is also tied to stronger awareness of inherited conditions seen more often in specific communities. Over time, descriptions became more precise, and ELP1 became the standard name used in current research and clinical care.